0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correction |

Update in Conflict of Interest Disclosure and Errors in the Supplement and Figure FREE

JAMA. 2016;316(3):350. doi:10.1001/jama.2016.6123.
Text Size: A A A
Published online

In the Original Investigation entitled “Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention,” published in the April 26, 2016, issue of JAMA,1 a conflict of interest disclosure needs to be updated. The disclosures for Drs Yeh and Mauri state that they have “a pending patent for development and use of the DAPT Score.” They have withdrawn this patent application since the article has been published and this disclosure has been removed from their disclosures. Also, due to an errant font, the Supplement had question marks in an eTable and an eFigure instead of the proper information. An updated Supplement has been provided. The bar graph in Figure 2 had the incorrect frequencies. This article was corrected online.

REFERENCES

Yeh  RW, Secemsky  EA, Kereiakes  DJ,  et al; DAPT Study Investigators.  Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315(16):1735-1749.
PubMed   |  Link to Article

Figures

Tables

References

Yeh  RW, Secemsky  EA, Kereiakes  DJ,  et al; DAPT Study Investigators.  Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315(16):1735-1749.
PubMed   |  Link to Article
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,010 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs